Yuval Cohen
Chief Executive Officer at Corbus Pharmaceuticals Holdings Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Corbus Pharmaceuticals Holdings Inc., 3 years.
Corbus Pharmaceuticals Holdings Inc.
Director · Chief Executive Officer
Chief executive roles
Corbus Pharmaceuticals Holdings Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Option exercise | +11,667 | $30.00 | $350,010 |
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −11,667 | $42.24 | $492,814 |
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Option exercise | +1,770 | $14.10 | $24,957 |
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −1,770 | $42.24 | $74,765 |
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Option exercise | +2,322 | $4.26 | $9,892 |
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −2,322 | $42.24 | $98,081 |
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −7,179 | $42.24 | $303,241 |
| Jun 17, 2024 | Corbus Pharmaceuticals Holdings Inc. | Option exercise | +9,333 | $30.00 | $279,990 |
| Jun 17, 2024 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −9,333 | $46.02 | $429,505 |
| Jun 17, 2024 | Corbus Pharmaceuticals Holdings Inc. | Option exercise | +1,770 | $4.26 | $7,540 |
| Jun 17, 2024 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −1,770 | $46.02 | $81,455 |
| Jun 14, 2024 | Corbus Pharmaceuticals Holdings Inc. | Option exercise | +16,830 | $14.10 | $237,303 |
| Jun 14, 2024 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −16,830 | $50.17 | $844,361 |
| Jun 14, 2024 | Corbus Pharmaceuticals Holdings Inc. | Option exercise | +12,487 | $4.26 | $53,195 |
| Jun 14, 2024 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −12,487 | $50.17 | $626,473 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.